Differential distribution of the normal and mutated forms of huntingtin in the human brain - PubMed (original) (raw)
doi: 10.1002/ana.410420507.
G Cancel, Y Trottier, D Devys, L Tora, Y Lutz, G Imbert, F Saudou, G Stevanin, Y Agid, A Brice, J L Mandel, E C Hirsch
Affiliations
- PMID: 9392570
- DOI: 10.1002/ana.410420507
Differential distribution of the normal and mutated forms of huntingtin in the human brain
I Gourfinkel-An et al. Ann Neurol. 1997 Nov.
Abstract
Huntington's disease is an inherited disorder caused by expansion of a CAG trinucleotide repeat in the IT15 gene, which leads to expansion of a polyglutamine tract within the protein called huntingtin. Despite the characterization of the IT15 gene and the mutation involved in the disease, the normal function of huntingtin and the effects of the mutation on its function and on its neuronal location remain unknown. To study whether mutated huntingtin has the same neuronal distribution and intracellular location as normal huntingtin, we analyzed immunohistochemically both forms of this protein in the brain of 5 controls and 5 patients with Huntington's disease. We show that the distribution of mutated huntingtin is, like that of the normal form, heterogeneous throughout the brain, but is not limited to vulnerable neurons in Huntington's disease, supporting the hypothesis that the presence of the mutated huntingtin in a neuron is not in itself sufficient to lead to neuronal death. Moreover, whereas normal huntingtin is detected in some neuronal perikarya, nerve fibers, and nerve endings, the mutated form is observed in some neuronal perikarya and proximal nerve processes but is not detectable in nerve endings. Our results suggest that the expression or processing of the mutated huntingtin in perikarya and nerve endings differs quantitatively or qualitatively from the expression of the normal form in the same neuronal compartments.
Similar articles
- Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form.
Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y, Weber C, Agid Y, Hirsch EC, Mandel JL. Trottier Y, et al. Nat Genet. 1995 May;10(1):104-10. doi: 10.1038/ng0595-104. Nat Genet. 1995. PMID: 7647777 - Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset.
Gourfinkel-An I, Cancel G, Duyckaerts C, Faucheux B, Hauw JJ, Trottier Y, Brice A, Agid Y, Hirsch EC. Gourfinkel-An I, et al. Neuroreport. 1998 Jun 1;9(8):1823-6. doi: 10.1097/00001756-199806010-00028. Neuroreport. 1998. PMID: 9665608 - Huntingtin localization in brains of normal and Huntington's disease patients.
Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M. Sapp E, et al. Ann Neurol. 1997 Oct;42(4):604-12. doi: 10.1002/ana.410420411. Ann Neurol. 1997. PMID: 9382472 - Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
Li SH, Li XJ. Li SH, et al. Trends Genet. 2004 Mar;20(3):146-54. doi: 10.1016/j.tig.2004.01.008. Trends Genet. 2004. PMID: 15036808 Review. - How does the Huntington's disease mutation damage cells?
Rubinsztein DC. Rubinsztein DC. Sci Aging Knowledge Environ. 2003 Sep 17;2003(37):PE26. doi: 10.1126/sageke.2003.37.pe26. Sci Aging Knowledge Environ. 2003. PMID: 13679594 Review.
Cited by
- Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease.
Miller JP, Holcomb J, Al-Ramahi I, de Haro M, Gafni J, Zhang N, Kim E, Sanhueza M, Torcassi C, Kwak S, Botas J, Hughes RE, Ellerby LM. Miller JP, et al. Neuron. 2010 Jul 29;67(2):199-212. doi: 10.1016/j.neuron.2010.06.021. Neuron. 2010. PMID: 20670829 Free PMC article. - Phase transition of WTAP regulates m6A modification of interferon-stimulated genes.
Cai S, Zhou J, Luo X, Zhang C, Jin S, Ren J, Cui J. Cai S, et al. Elife. 2025 May 27;13:RP100601. doi: 10.7554/eLife.100601. Elife. 2025. PMID: 40424294 Free PMC article. - Huntington disease models and human neuropathology: similarities and differences.
Vonsattel JP. Vonsattel JP. Acta Neuropathol. 2008 Jan;115(1):55-69. doi: 10.1007/s00401-007-0306-6. Epub 2007 Nov 3. Acta Neuropathol. 2008. PMID: 17978822 Free PMC article. Review. - Hunting for the cause: Evidence for prion-like mechanisms in Huntington's disease.
Donnelly KM, Coleman CM, Fuller ML, Reed VL, Smerina D, Tomlinson DS, Pearce MMP. Donnelly KM, et al. Front Neurosci. 2022 Aug 24;16:946822. doi: 10.3389/fnins.2022.946822. eCollection 2022. Front Neurosci. 2022. PMID: 36090278 Free PMC article. Review. - Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.
Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ. Gutekunst CA, et al. J Neurosci. 1999 Apr 1;19(7):2522-34. doi: 10.1523/JNEUROSCI.19-07-02522.1999. J Neurosci. 1999. PMID: 10087066 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical